TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novavax AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
73,932
|
141,170
|
95,913 |
| Financial expenses |
61,294
|
69,397
|
41,934 |
| Earnings before taxes |
17,565
|
46,565
|
-10,909 |
| EBITDA |
20,167
|
48,255
|
-9,826 |
| Total assets |
325,859
|
336,782
|
351,398 |
| Current assets |
18,521
|
237,002
|
251,164 |
| Current liabilities |
118,866
|
149,274
|
203,418 |
| Equity capital |
206,993
|
187,508
|
147,980 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
195
|
167
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
63.5%
|
55.7%
|
42.1% |
| Turnover per employee |
379
|
845 | |
| Profit as a percentage of turnover |
23.8%
|
33.0%
|
-11.4% |
| Return on assets (ROA) |
24.2%
|
34.4%
|
8.8% |
| Current ratio |
15.6%
|
158.8%
|
123.5% |
| Return on equity (ROE) |
8.5%
|
24.8%
|
-7.4% |
| Change turnover |
-67,650
|
53,027
|
57,272 |
| Change turnover % |
-48%
|
60%
|
148% |
| Chg. No. of employees |
28
|
167
|
-57 |
| Chg. No. of employees % | 17% | -100% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.